# Effect of BIBW 2948 BS in COPD

> **NCT00423137** · PHASE2 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 48 (actual)

## Conditions studied

- Pulmonary Disease, Chronic Obstructive
- Bronchitis, Chronic

## Interventions

- **DRUG:** BIBW 2948 BS
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00423137
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-01-17
- **Primary completion:** 2008-07-09
- **Final completion:** 2008-07-09
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2021-11-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00423137

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00423137, "Effect of BIBW 2948 BS in COPD". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00423137. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*